Symlin (pramlintide) caused nausea in 9-29% of patients depending on dose

Posted by .(JavaScript must be enabled to view this email address)
Thursday, September 11, 2008 11:21 am Email this article
Symlin (pramlintide) caused nausea in 9 percent of patients given 240 mcg three times per day and 29 percent of patients given 360 mcg three times per day versus 2 percent of those given a placebo. REFERENCE

Smith S, Aronne L, Burns C, Kesty N, Halseth A, Weyer C. Sustained weight loss following 12-month pramlintide treatment as an adjunct to lifestyle intervention in obesity. Diabetes Care. 2008 Sep, 31(9):1816-23.

AUTHOR’S CONTACT INFORMATION

Christian Weyer, MD
Amylin Pharmaceuticals
San Diego, California USA
.(JavaScript must be enabled to view this email address)

Steve R. Smith, MD
Pennington Biomedical Research Center
Louisiana State University
Baton Rouge, Louisiana USA
.(JavaScript must be enabled to view this email address)

 

Articles on the same subject can be found here:

• Diabetes

• Symlin (pramlintide)